Complementary vertebrate Wac models exhibit phenotypes relevant to DeSanto-Shinawi Syndrome
Kang‐Han LeeiD, April M StaffordiD, Maria Pacheco-Vergara, Karol CichewicziD, César P. CanalesiD, Nicolas SebaniD, Melissa CoreaiD, Darlene RahbarianiD, Kelly E. Bonekamp, Grant R. Gillie, Dariangelly Pacheco-Cruz, Alyssa M GilliD, Hye-Eun Hwang, Yeong-Eun Kim, Katie L Uhl, Tara E Jager, Marwan S. ShinawiiD, Xiaopeng LiiD, Andre Obenaus, Shane Crandall, Juhee JeongiD, Alex NordiD, Cheol‐Hee KimiD, Daniel L. VogtiD
Abstract
Monogenic syndromes are associated with neurodevelopmental changes that result in cognitive impairments and neurobehavioral phenotypes including autism and seizures. Limited studies and resources are available to make meaningful headway into the underlying molecular mechanisms that result in these symptoms. One such example is DeSanto-Shinawi Syndrome (DESSH), a rare disorder caused by pathogenic variants in the WAC gene. Individuals with DESSH syndrome exhibit a recognizable craniofacial gestalt, developmental delay/intellectual disability, neurobehavioral symptoms that include autism, ADHD, behavioral difficulties and seizures. However, no thorough studies from a vertebrate model exist to understand how these changes occur. To overcome this, we developed both murine and zebrafish Wac/wac deletion mutants and studied whether their phenotypes recapitulate those described in individuals with DESSH syndrome. We first show that the two Wac models exhibit craniofacial and behavioral changes, reminiscent of abnormalities found in DESSH syndrome. In addition, each model revealed impacts to GABAergic neurons and further studies showed that the mouse mutants are susceptible to seizures, changes in brain volumes that are different between sexes and relevant behaviors. Finally, we uncovered transcriptional impacts of Wac loss of function in mice that will pave the way for future molecular studies into DESSH. These studies present two new animals that begin to uncover some biological underpinnings of DESSH syndrome and elucidate the biology of Wac.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A murine Wac model exhibits phenotypes relevant to DeSanto-Shinawi Syndrome
April M Stafford, Maria Pacheco-Vergara, … Daniel L. Vogt·bioRxiv·Jan 24, 2022
- Neurobehavioral impacts of the autism risk gene, WAC: Studies involving C. elegans and Mice
Napissara Boonpraman, Da-Woon Kim, … Shreesh Raj Sammi·Molecular NeurobiologyPeer-reviewed·Jan 1, 2026
- Neurodevelopmental defects in Dravet syndrome Scn1a+/- mice: targeting GABA-switch rescues behavioral dysfunctions but not seizures and mortality.
Lara Pizzamiglio, Fabrizio Capitano, … Massimo Mantegazza·Neurobiology of DiseasePeer-reviewed·Feb 26, 2025
- Deficiency of the ywhaz gene, involved in neurodevelopmental disorders, alters brain activity and behaviour in zebrafish
Ester Antón-Galindo, Elisa Dalla Vecchia, … Noèlia Fernàndez-castillo A·Molecular PsychiatryPeer-reviewed·May 2, 2022
- Wolf-Hirschhorn Syndrome-associated genes are enriched in motile neural crest and affect craniofacial development in Xenopus laevis
Alexandra N. Mills, Elizabeth A. Bearce, … Laura Anne Lowery·Frontiers in PhysiologyPeer-reviewed·Apr 12, 2019
- Gtf2i and Gtf2ird1 mutation are not sufficient to reproduce mouse phenotypes caused by the Williams Syndrome critical region
N. D. Kopp, K. McCullough, … J. D. Dougherty·bioRxiv·Feb 24, 2019